LBA33 ICON9: International Phase III Randomized Study to Evaluate the Efficacy of Maintenance Therapy with Olaparib and Cediranib or Olaparib Alone in Patients with Relapsed Platinum-Sensitive Ovarian Cancer Following a Response to Platinum-Based Chemotherapy

S. Nicum,J.A. Ledermann,L. Mileshkin,G.C. Jayson,C. Gourley,A. Michael,R. Lord, H. Mackay, M. Hall,L. Tookman, S. Banerjee, P. Harnett, I. Macdonald, Y.C. Lee, O. Elyashiv, K. Wilkinson,L. Farrelly,N. Counsell

Annals of Oncology（2024）

Cited 0|Views4

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined